To battle the coronavirus, strong regulatory protection from the FDA is essential.
L’expertise universitaire, l’exigence journalistique
Articles sur Food and Drug Administration (FDA)
Affichage de 101 à 120 de 161 articles
The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.
Among the more than 20,000 drugs approved by the FDA, there may be some that can treat COVID-19. A team at the University of California, San Francisco, is identifying possible candidates.
Americans love their supplements, but some of the products are contaminated with heavy metals, bacteria and toxic fungi. The FDA has little control because of a law passed in 1994.
MDMA is better known as the party psychedelic Ecstasy or Molly. Used clinically, together with psychotherapy, it reduces symptoms of post-traumatic stress disorder, and shows promise with couples.
Researchers are looking for ways to determine who’s most at risk for dementia and also ways to detect it early. A scientist who has studied low blood pressure makes a case for a link between the two.
With fear of a diagnosis of Alzheimer’s a constant concern for many seniors, they turn to supplements. A recent study suggests they’d be better off keeping their money.
E-cigarettes are unsafe for children, but some e-cig companies are using cartoons, which have been shown to appeal to youth. Should restrictions be in place, as they are for traditional cigarettes?
Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
The FDA has given the green light to sell the first genetically engineered animal – farmed salmon –in the US.
With Gottlieb’s departure from the FDA imminent, what should we expect from the FDA? How is it likely to regulate the still controversial genetically engineered foods?
According to current regulations, animals that have been genetically edited, like pigs or cows, are considered drugs. What are the consequences of such rules on American livestock and agriculture?
A safety committee convened by the FDA has declared esketamine safe for severe depression. But isn’t this drug the same as ketamine, an illegal street drug? A medical anthropologist explains.
Most Americans underestimate how many calories nutritionists recommend they consume each day, which means maybe you can probably have one more treat without feeling guilty.
Don’t eat raw cookie dough in a house, with a mouse, or here, there or anywhere, wrote the FDA commissioner last week. A public health scholar sees – and tastes – things differently.
Men who can’t take drugs for erectile dysfunction and overweight people who can’t lose weight sometimes turn to natural supplements, thinking they are safe. Many times, they are not.
E-cigarettes are hotly debated because of the uncertainty of whether they are a gateway to cigarette smoking for teens, or an aid to smoking cessation. One thing is clear: They are not biodegradable.
The Trump administration wants to streamline federal food safety efforts under one roof as part of a sweeping new plan to reorganize government.
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?
An increasing list of rare diseases can now be treated with gene therapy. But we need to figure out a way to make them affordable.
Les contributeurs les plus fréquents
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Law, Villanova School of Law
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Joel Lexchin est un·e adhérent·e de The Conversation
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor and Dean, School of Public Health, Georgia State University
-
Instructor of Human Immunology, Emory University
-
Associate Professor of Pediatrics, University of Virginia
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor of Law, George Washington University
-
Doctorate in Health Sciences candidate, George Washington University
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
